Cortexyme raised a round of funding on February 11, 2015. Investors include
JLabs.
Cortexyme is a private company based in San Francisco, California developing therapeutics for Alzheimer's disease and other degenerative disorders based on the discovery by Stephen Dominy, MD that a s…
